A new architecture called the Large Discovery Model pairs a generative proposer with a Bayesian surrogate that grades candidates using accumulated experimental evidence rather than the generator's own confidence. Across neural network training, antibody design and molecular optimisation, the researchers report a 2.4 times greater reduction in a validation training metric, an 18.2 percent relative decrease in antibody binding energy, and more than 60 percent relative gains on molecular multi-objective performance compared with either language-model reflection alone or traditional statistical search.
Key facts
- Reported gains: 2.4x greater reduction in validation bits-per-byte, 18.2 percent relative decrease in binding energy, and over 60 percent relative gains in molecular multi-objective performance.
- Published August 2026 as arXiv:2608.15669, with a project page and public code.
- Evaluated across three design modalities: neural network training, antibody design, and molecular optimisation.
- The core architectural claim is a generative model coupled to a Bayesian non-parametric reward surrogate, both updated continually as experimental results arrive.
The problem this attacks is specific and increasingly common. Scientific discovery often means optimising something expensive to measure across a space that is vast, structured and open-ended: molecules, protein sequences, computer programs. Large language models are good at proposing candidates in such spaces because they carry an expressive prior over what a plausible molecule or program looks like. What they are bad at is knowing whether any given proposal is actually good.
The paper says this plainly: model "likelihoods and self-assessments are unreliable proxies for the objectives and calibrated epistemic uncertainty, especially for novel candidates outside the observed data distribution." That last clause is the crux. A model's confidence is least trustworthy exactly where discovery happens, which is on candidates unlike anything it has seen.
So the architecture splits the two jobs. The generative model proposes and refines. A separate Bayesian non-parametric surrogate predicts how each candidate will actually perform and, critically, how confident that prediction deserves to be. Combining prediction and uncertainty produces a value that steers which candidates get generated, refined and selected next. Both a discovery memory and the surrogate update continuously as each new experimental observation comes back.
The useful analogy is a lab with two people in it. One is a brilliant, fluent chemist who can sketch a hundred plausible molecules an hour and is genuinely enthusiastic about all of them. The other is a sceptical statistician who has been keeping a notebook of every compound the lab has ever tested and what happened, and who can say both "this one looks promising" and "I have no idea about this one, which is exactly why we should try it." Neither works well alone. The paper's claim is that most current AI-for-science pipelines only hired the first person.
The word doing the most work in the paper's title is "empirically grounded." It means the signal driving the search comes from external evidence, experiments, simulations, or computational tests, and never from the model's own likelihood or self-confidence. That is a design commitment with teeth, and it is the opposite of the reflection-based agent loops that dominated the last two years.
Why it matters connects to a running problem in this field. Systems that let a model evaluate its own output tend to converge on things that look good to the model, which is the same failure our lesson on reward hacking describes and a close cousin of the sycophancy problem in chat models. An independent surrogate scored on real measurements breaks that loop. The trade is cost: you need real evaluations, and they are slow.
The honest caveat is one the paper states itself. It draws a hard boundary around problems whose search space, objective, or evaluation are not yet specifiable. This is discovery over a formalised search process, not an all-purpose science oracle. And the reported wins are benchmarked improvements in program, antibody and molecule search rather than independently novel scientific findings. Nothing here was taken to a wet lab and confirmed to work in the way Anthropic's protein binders were.
It arrives alongside a broader move to make discovery measurable. Apodex Discovery surveyed 561 industries across 16 sectors, assembled 423 high-value real-world problems, released 20 as executable environments, and built a rubric that scores an investigation's tools, repair, alternatives, coherence, evidence and scope independently of whether the final answer was right. That is a notable design choice: it grades the reasoning rather than the outcome, in a field where a lucky answer and a sound method are usually collapsed into the same number.
We have covered adjacent findings before, including a claim that AI flattens scientific discovery and a study where frontier agents produced three genuinely new ideas out of 252. For the statistical machinery underneath this paper, our lessons on Bayesian updating and Bayesian optimization cover how a surrogate model turns a small number of expensive experiments into a search strategy.
Originally published on Ground Truth, where every claim is checked against the primary source.
